Galectin Therapeutics Inc (GALT) — Cash Flow-to-Debt Ratio
Galectin Therapeutics Inc (GALT) has a Cash Flow-to-Debt Ratio of -0.04x as of December 2025, meaning its operating cash flow of $-6.04 Million could theoretically repay 0% of its total liabilities ($145.73 Million) in one year. See how liquid is Galectin Therapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Galectin Therapeutics Inc Cash Flow-to-Debt Ratio (2000–2025)
Historical debt coverage capacity for Galectin Therapeutics Inc across 26 annual periods. Also explore GALT net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Galectin Therapeutics Inc (2000–2025)
Year-by-year debt coverage analysis for Galectin Therapeutics Inc. For market capitalisation and broader financial context, see market cap of Galectin Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.16x | $-23.88 Million | $145.73 Million | ▲ +52.7% |
| 2024 | -0.35x | $-41.77 Million | $120.56 Million | ▲ +7.1% |
| 2023 | -0.37x | $-32.97 Million | $88.44 Million | ▲ +35.8% |
| 2022 | -0.58x | $-31.06 Million | $53.48 Million | ▲ +6.3% |
| 2021 | -0.62x | $-24.31 Million | $39.21 Million | ▲ +83.7% |
| 2020 | -3.81x | $-20.60 Million | $5.41 Million | ▼ -0.9% |
| 2019 | -3.78x | $-10.85 Million | $2.87 Million | ▲ +21.8% |
| 2018 | -4.83x | $-10.18 Million | $2.11 Million | ▲ +9.8% |
| 2017 | -5.35x | $-15.89 Million | $2.97 Million | ▼ -23.3% |
| 2016 | -4.34x | $-16.41 Million | $3.78 Million | ▲ +65.2% |
| 2015 | -12.49x | $-16.98 Million | $1.36 Million | ▼ -71.1% |
| 2014 | -7.30x | $-12.43 Million | $1.70 Million | ▼ -142.4% |
| 2013 | -3.01x | $-7.48 Million | $2.49 Million | ▲ +34.0% |
| 2012 | -4.56x | $-7.50 Million | $1.64 Million | ▼ -78.0% |
| 2011 | -2.56x | $-5.68 Million | $2.21 Million | ▼ -560.4% |
| 2010 | -0.39x | $-3.10 Million | $7.99 Million | ▲ +51.1% |
| 2009 | -0.79x | $-3.89 Million | $4.90 Million | ▲ +80.1% |
| 2008 | -3.98x | $-4.67 Million | $1.17 Million | ▼ -241.3% |
| 2007 | -1.17x | $-5.48 Million | $4.71 Million | ▼ -10.1% |
| 2006 | -1.06x | $-6.76 Million | $6.38 Million | ▲ +76.2% |
| 2005 | -4.44x | $-6.13 Million | $1.38 Million | ▲ +29.5% |
| 2004 | -6.30x | $-6.33 Million | $1.00 Million | ▲ +42.6% |
| 2003 | -10.99x | $-4.15 Million | $377.91K | ▼ -145.6% |
| 2002 | -4.47x | $-2.98 Million | $666.79K | ▼ -36.9% |
| 2001 | -3.27x | $-1.80 Million | $550.70K | ▼ -553.5% |
| 2000 | -0.50x | $-90.00K | $180.00K | — |